Leighl NB - Search Results

1

Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.

O'Kane GM, Labbé C, Doherty MK, Young K, Albaba H, Leighl NB. O'Kane GM, et al. Among authors: leighl nb. Oncologist. 2017 Jan;22(1):70-80. doi: 10.1634/theoncologist.2016-0164. Epub 2016 Aug 17. Oncologist. 2017. PMID: 27534573 Free PMC article. Review.

2

Docetaxel in non-small cell lung cancer: impact on quality of life and pharmacoeconomics.

Horn L, Visbal A, Leighl NB. Horn L, et al. Among authors: leighl nb. Drugs Aging. 2007;24(5):411-28. doi: 10.2165/00002512-200724050-00005. Drugs Aging. 2007. PMID: 17503897 Review.

3

A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium.

Taylor SK, Chia S, Dent S, Clemons M, Agulnik M, Grenci P, Wang L, Oza AM, Ivy P, Pritchard KI, Leighl NB. Taylor SK, et al. Among authors: leighl nb. Oncologist. 2010;15(8):810-8. doi: 10.1634/theoncologist.2010-0081. Epub 2010 Aug 3. Oncologist. 2010. PMID: 20682606 Free PMC article. Clinical Trial.

4

Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).

Leighl NB, Zatloukal P, Mezger J, Ramlau R, Moore N, Reck M, Manegold C. Leighl NB, et al. J Thorac Oncol. 2010 Dec;5(12):1970-6. doi: 10.1097/JTO.0b013e3181f49c22. J Thorac Oncol. 2010. PMID: 20978447 Free article. Clinical Trial.

5

How affordable are targeted therapies in non-small cell lung cancer?

Coate LE, Leighl NB. Coate LE, et al. Among authors: leighl nb. Curr Treat Options Oncol. 2011 Mar;12(1):1-11. doi: 10.1007/s11864-010-0137-x. Curr Treat Options Oncol. 2011. PMID: 21267683 Review.

6

KRAS mutations as prognostic and predictive markers in non-small cell lung cancer.

Martin P, Leighl NB, Tsao MS, Shepherd FA. Martin P, et al. Among authors: leighl nb. J Thorac Oncol. 2013 May;8(5):530-42. doi: 10.1097/JTO.0b013e318283d958. J Thorac Oncol. 2013. PMID: 23524403 Free article. Review.

7

Barriers and challenges to global clinical cancer research.

Seruga B, Sadikov A, Cazap EL, Delgado LB, Digumarti R, Leighl NB, Meshref MM, Minami H, Robinson E, Yamaguchi NH, Pyle D, Cufer T. Seruga B, et al. Among authors: leighl nb. Oncologist. 2014 Jan;19(1):61-7. doi: 10.1634/theoncologist.2013-0290. Epub 2013 Dec 9. Oncologist. 2014. PMID: 24323390 Free PMC article.

8

The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment.

Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA. Bombard Y, et al. Among authors: leighl nb. Oncologist. 2015 Apr;20(4):351-6. doi: 10.1634/theoncologist.2014-0268. Epub 2015 Mar 6. Oncologist. 2015. PMID: 25746345 Free PMC article.

9

Expectations in the care of lung cancer.

Lilenbaum R, Leighl NB, Neubauer M. Lilenbaum R, et al. Among authors: leighl nb. Am Soc Clin Oncol Educ Book. 2015:e420-4. doi: 10.14694/EdBook_AM.2015.35.e420. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993205 Free article. Review.

10

Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor.

Doherty MK, Jao K, Shepherd FA, Hazrati LN, Leighl NB. Doherty MK, et al. Among authors: leighl nb. J Thorac Oncol. 2015 Oct;10(10):e100-1. doi: 10.1097/JTO.0000000000000587. J Thorac Oncol. 2015. PMID: 26398825 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page